Quince Therapeutics S.p.a.

This completed Phase 3 trial tested whether a medication called EryDex could help control neurological symptoms in children with ataxia telangiectasia, a rare genetic disorder that affects movement and coordination. The study involved 105 children aged 6 and older who received ei…